4.4 Review

Chemokines in rheumatic diseases

Journal

CURRENT DRUG TARGETS
Volume 7, Issue 1, Pages 91-102

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945006775270231

Keywords

chemokines; chemokine receptors; rheumatic diseases; rheumatoid arthritis; synovial tissue; biological therapy

Funding

  1. NHLBI NIH HHS [HL-58695] Funding Source: Medline
  2. NIAID NIH HHS [AI-40987] Funding Source: Medline
  3. NIAMS NIH HHS [AR-048267] Funding Source: Medline
  4. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058695] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040987, R21AI040987] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048267] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjogren's syndrome, mixed connective tissue disease, polymyositis/dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available